The pharmacological inhibition of Jak2/Stat3 leads to an antitumor immune response that enhances the efficacy of chemotherapy, suggesting that the oncogene PTEN is involved in immunomodulation of the tumor microenvironment through SASP. This evidence concerns the gene STAT3 and neoplasm.